{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=56", "query": { "intervention": "ADM", "page": 56 }, "page_size": 10 }, "pagination": { "page": 56, "page_size": 10, "total_count": 4271, "total_pages": 428, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=57&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=55&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-13T00:29:23.509Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06630845", "title": "Comparison of Whole Body DWI to FDG PET", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Metastatic Cancer" ], "interventions": [ { "name": "Fluorodeoxyglucose F18", "type": "DRUG" }, { "name": "Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI)", "type": "PROCEDURE" }, { "name": "Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI)", "type": "PROCEDURE" }, { "name": "General Electric (GE) SIGNA PET/MR", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "PROCEDURE", "DEVICE" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2025-02-06", "completion_date": "2027-02-28", "has_results": false, "last_update_posted_date": "2026-11-09", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06630845" }, { "nct_id": "NCT05080972", "title": "Mobile HIV Prevention App for Black Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mobile Phone Use", "Hiv", "Stigma, Social" ], "interventions": [ { "name": "in-the-kNOW mobile app", "type": "BEHAVIORAL" }, { "name": "Control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "44 Years", "sex": "FEMALE", "summary": "18 Years to 44 Years · Female only" }, "enrollment_count": 56, "start_date": "2022-02-05", "completion_date": "2024-12-31", "has_results": true, "last_update_posted_date": "2026-03-16", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05080972" }, { "nct_id": "NCT03275519", "title": "Antibiotic Use in Distal Hypospadias Repair", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypospadias" ], "interventions": [ { "name": "Randomization to not receive prophylactic antibiotics after surgery.", "type": "OTHER" }, { "name": "Randomization to receive prophylactic antibiotics after surgery", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Arkansas Children's Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Months", "maximum_age": "6 Years", "sex": "MALE", "summary": "3 Months to 6 Years · Male only" }, "enrollment_count": 48, "start_date": "2015-01-19", "completion_date": "2017-04-19", "has_results": false, "last_update_posted_date": "2017-09-07", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03275519" }, { "nct_id": "NCT01125267", "title": "Promoting Adherence to Treatment in Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "multifamily group-adherence", "type": "BEHAVIORAL" }, { "name": "multifamily group-standard", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 174, "start_date": "2003-04", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2010-05-18", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 1, "location_summary": "Granada Hills, California", "locations": [ { "city": "Granada Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01125267" }, { "nct_id": "NCT01840592", "title": "Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatocellular Carcinoma" ], "interventions": [ { "name": "Sorafenib", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2013-04", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 6, "location_summary": "Basking Ridge, New Jersey • Commack, New York • Harrison, New York + 3 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Rockville Centre", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01840592" }, { "nct_id": "NCT07158892", "title": "Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Non-traumatic Musculoskeletal Conditions", "Carpal Tunnel Syndrome (CTS)", "Lateral Epicondylitis", "Osteoarthritis", "Trigger Digit", "Dupuytren Contracture", "Rotator Cuff Tendinopathy", "De Quervain Disease" ], "interventions": [ { "name": "Diagnostic Advance Care Planning Discussion", "type": "BEHAVIORAL" }, { "name": "Informational Statement Only", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Texas at Austin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 220, "start_date": "2026-10-25", "completion_date": "2027-03-01", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07158892" }, { "nct_id": "NCT00002665", "title": "SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia", "Neutropenia", "Thrombocytopenia" ], "interventions": [ { "name": "asparaginase", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "daunorubicin hydrochloride", "type": "DRUG" }, { "name": "dexamethasone", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "mercaptopurine", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "thioguanine", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "allogeneic bone marrow transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "15 Years to 65 Years" }, "enrollment_count": 50, "start_date": "1995-07", "completion_date": "2003-12", "has_results": false, "last_update_posted_date": "2015-03-06", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 83, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 54 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002665" }, { "nct_id": "NCT00952081", "title": "A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension", "Brain Tumor", "Epilepsy" ], "interventions": [ { "name": "Clevidipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 22, "start_date": "2009-07", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2015-02-09", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00952081" }, { "nct_id": "NCT00003992", "title": "Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "trastuzumab", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" }, { "name": "tamoxifen citrate", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 200, "start_date": "1999-08", "completion_date": "2009-03", "has_results": false, "last_update_posted_date": "2013-06-03", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 44, "location_summary": "Palo Alto, California • Stanford, California • Denver, Colorado + 35 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003992" }, { "nct_id": "NCT01593111", "title": "Environmental Intervention Versus Standard Care to Reduce Pharmacologic Therapy for Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Environmental Intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 243, "start_date": "2011-04", "completion_date": "2013-09", "has_results": false, "last_update_posted_date": "2022-02-04", "last_synced_at": "2026-11-13T00:29:23.509Z", "location_count": 2, "location_summary": "New York, New York • The Bronx, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01593111" } ] }